Kinesia HomeView - Home Diary Comparison

Completed · Not applicable

Conditions studied: Parkinson's Disease

In brief

The objective is to compare the sensitivity and test-retest reliability of Kinesia HomeView to electronic and hand-written diaries for tracking medication state in the home. Demonstrating comparable or superior results will further support use of the Kinesia HomeView system as an outcome measure in clinical drug trials.

Key facts

Study ID

NCT01920425

Run by

Great Lakes NeuroTechnologies Inc.

People needed

2

Starts

2013-07-01

Expected to finish

2015-09-01

Last updated by the study team

2016-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of Parkinson's disease
• On a stable antiparkinsonian medication regimen that includes levodopa for at least 4 weeks
• Experiencing dyskinesia more than 25% of the waking day (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 32)
• With dyskinesias at least moderately disabling (score ≥ 2 on Unified Parkinson's Disease Rating Scale item 33)
• Capable of accurately completing diaries
• Capable of accurately using Kinesia HomeView

You may not qualify if…

• Significant medical or psychiatric illness
• Subjects not capable of following the required clinical instructions
• Serious medical conditions that would compromise safety

Where it is running

• Great Lakes NeuroTechnologies Inc — Valley View, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.